XML 60 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisition, Equity-Method Investment and Licensing Arrangements - Equity Method Investment Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2020
Sep. 29, 2019
Sep. 27, 2020
Sep. 29, 2019
Dec. 31, 2019
Jul. 31, 2019
Schedule of Equity Method Investments [Line Items]            
Gain on completion of Consumer Healthcare JV transaction $ 0 $ 8,087 $ 6 $ 8,087    
Equity-method investments 15,949   15,949   $ 17,133  
GSK Consumer Healthcare [Member]            
Schedule of Equity Method Investments [Line Items]            
Equity method investment, ownership percentage   32.00%   32.00%   32.00%
Gain on completion of Consumer Healthcare JV transaction   $ 8,100        
Gain on completion of Consumer Healthcare JV transaction, after-tax   5,400        
Equity-method investments 15,800   15,800   17,000  
Decrease due to foreign currency translation     617      
Dividend received     825      
Equity method investment earnings 166   306      
Fair value of equity method investment   15,700   $ 15,700   $ 15,700
Underlying equity in net assets         11,000 11,200
Difference between carrying amount and underlying equity         $ 4,800 $ 4,500
GSK [Member] | GSK Consumer Healthcare [Member]            
Schedule of Equity Method Investments [Line Items]            
Equity method investment, ownership percentage           68.00%
OID [Member] | GSK Consumer Healthcare [Member]            
Schedule of Equity Method Investments [Line Items]            
Excess basis amortization and write-off $ 62   $ 110      
Consumer Healthcare [Member] | Held-for-sale [Member]            
Schedule of Equity Method Investments [Line Items]            
Pre-tax income attributable to disposal group   $ 100   $ 654    
Minimum [Member] | GSK Consumer Healthcare [Member]            
Schedule of Equity Method Investments [Line Items]            
Excess basis amortization period     8 years      
Maximum [Member] | GSK Consumer Healthcare [Member]            
Schedule of Equity Method Investments [Line Items]            
Excess basis amortization period     20 years